What We’re Reading: Examining Generic Drug Shortages; Long COVID Research; Hospital Cyberattacks Increase
The Federal Trade Commission and HHS will examine generic drug shortage causes; the Biden administration recently dedicated an additional $515 million to a major initiative to study long COVID; cybersecurity experts warn that US hospitals are at risk for attacks and the government is doing little to prevent such breaches.
US Agencies Open Inquiry Into Generic Drug Shortages
The Federal Trade Commission (FTC) and HHS have announced that they will examine the causes of generic drug shortages and the practices of supply chain middlemen, according to
NIH Long Covid Research Funding Gets a Nearly 50% Boost
The Biden administration recently dedicated an additional $515 million to a major initiative to study long COVID, a nearly 50% increase to the project’s budget, according to
Cyberattacks on Hospitals are Likely to Increase, Experts Warn
Cybersecurity experts are warning that hospitals around the US are at risk for attacks while the government is doing too little to prevent such breaches, according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025